Achieve Life Sciences, Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Achieve Life Sciences, Inc. (ACHV) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $10.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2018-05-09
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2018-03-31 was $10.00K, a 99.89% decline year-over-year.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-12-31 was $272.00K, a 97.39% decline year-over-year.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was $2.15M, a 74.69% decline year-over-year.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $760.00K.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $12.65M, a 19.23% increase from fiscal 2016.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $10.61M.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$2.00M, a 137.27% decline from fiscal 2014.
- Achieve Life Sciences, Inc. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was $5.37M, a 83.45% decline from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2018-03-31 | $10.00K 10-Q · filed 2018-05-09 | $282.00K derived: sum of 2 quarters · filed 2018-05-09 | $2.43M derived: sum of 3 quarters · filed 2018-05-09 | $3.19M derived: sum of 4 quarters · filed 2018-05-09 | |
| 2017-12-31 | $272.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.42M derived: sum of 2 quarters · filed 2018-03-01 | $3.18M derived: sum of 3 quarters · filed 2018-03-01 | $12.65M 10-K · filed 2018-03-01 | |
| 2017-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.91M derived: sum of 2 quarters · filed 2017-11-09 | $12.38M 10-Q · filed 2017-11-09 | $22.79M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2017-06-30 | $760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $10.23M 10-Q · filed 2017-07-31 | $20.64M derived: sum of 3 quarters · filed 2017-07-31 | $29.13M derived: sum of 4 quarters · filed 2017-07-31 | |
| 2017-03-31 | $9.47M 10-Q · filed 2017-05-15 | $19.88M derived: sum of 2 quarters · filed 2017-05-15 | $28.36M derived: sum of 3 quarters · filed 2017-05-15 | $26.39M derived: sum of 4 quarters · filed 2017-07-31 | |
| 2016-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $18.90M derived: sum of 2 quarters · filed 2017-02-23 | $16.92M derived: sum of 3 quarters · filed 2017-07-31 | $10.61M 10-K · filed 2017-02-23 | |
| 2016-09-30 | $8.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $6.50M derived: sum of 2 quarters · filed 2017-07-31 | $194.00K 10-Q · filed 2016-11-10 | $2.77M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$8.29M 10-Q · filed 2017-07-31 | -$5.71M derived: sum of 3 quarters · filed 2018-03-01 | -$17.01M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | -$6.31M 10-Q · filed 2017-05-15 | -$3.73M derived: sum of 2 quarters · filed 2018-03-01 | -$15.04M derived: sum of 3 quarters · filed 2018-03-01 | -$12.19M derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$8.72M derived: sum of 2 quarters · filed 2018-03-01 | -$5.88M derived: sum of 3 quarters · filed 2018-03-01 | -$2.00M 10-K · filed 2018-03-01 | -$2.08M 10-K · filed 2016-03-09 |
| 2015-09-30 | -$11.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$8.46M derived: sum of 2 quarters · filed 2016-11-10 | -$4.58M 10-Q · filed 2016-11-10 | -$18.70M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $6.72M 10-Q · filed 2016-08-04 | -$7.40M derived: sum of 3 quarters · filed 2017-02-23 | -$12.47M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2015-03-31 | $3.88M 10-Q · filed 2016-05-12 | -$10.24M derived: sum of 2 quarters · filed 2017-02-23 | -$15.32M derived: sum of 3 quarters · filed 2017-02-23 | -$6.46M derived: sum of 4 quarters · filed 2017-02-23 | |
| 2014-12-31 | -$14.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$19.20M derived: sum of 2 quarters · filed 2017-02-23 | -$10.33M derived: sum of 3 quarters · filed 2017-02-23 | $5.37M 10-K · filed 2017-02-23 | |
| 2014-09-30 | -$5.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $3.79M derived: sum of 2 quarters · filed 2015-11-12 | $19.49M 10-Q · filed 2015-11-12 | $28.67M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-06-30 | $8.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $24.56M 10-Q · filed 2015-08-13 | $33.74M derived: sum of 3 quarters · filed 2016-03-09 | $38.15M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2014-03-31 | $15.70M 10-Q · filed 2015-05-14 | $24.88M derived: sum of 2 quarters · filed 2016-03-09 | $29.29M derived: sum of 3 quarters · filed 2016-03-09 | $36.89M derived: sum of 4 quarters · filed 2016-03-09 | |
| 2013-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $13.59M derived: sum of 2 quarters · filed 2016-03-09 | $21.19M derived: sum of 3 quarters · filed 2016-03-09 | $32.43M 10-K · filed 2016-03-09 | |
| 2013-09-30 | $4.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $12.01M derived: sum of 2 quarters · filed 2014-10-30 | $23.25M 10-Q · filed 2014-10-30 | ||
| 2013-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $18.84M 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $11.24M 10-Q · filed 2014-04-30 | ||||
| 2012-12-31 | -$21.19M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |